These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6143773)

  • 21. Deprenyl in attention deficit associated with Tourette's syndrome.
    Jankovic J
    Arch Neurol; 1993 Mar; 50(3):286-8. PubMed ID: 8442708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Pringsheim T
    J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 24. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
    Robertson MM
    Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic tic disorders--chronic mortor or vocal tic disorders and de la Tourette's syndrome].
    Kano Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):65-71. PubMed ID: 14626066
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome.
    Robertson MM; Eapen V
    Clin Neuropharmacol; 1992 Oct; 15(5):408-25. PubMed ID: 1358442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychologic and neuropsychologic aspects of Tourette's syndrome.
    Golden GS
    Neurol Clin; 1984 Feb; 2(1):91-102. PubMed ID: 6150429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal ganglia structure in Tourette's disorder and/or attention-deficit/hyperactivity disorder.
    Forde NJ; Zwiers MP; Naaijen J; Akkermans SEA; Openneer TJC; Visscher F; Dietrich A; Buitelaar JK; Hoekstra PJ
    Mov Disord; 2017 Apr; 32(4):601-604. PubMed ID: 27862303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemoline-induced Tourette's disorder: a case report.
    Bachman DS
    Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donepezil for Tourette's disorder and ADHD.
    Hoopes SP
    J Clin Psychopharmacol; 1999 Aug; 19(4):381-2. PubMed ID: 10440471
    [No Abstract]   [Full Text] [Related]  

  • 31. Attention deficit hyperactivity disorder in the presence of Tourette syndrome.
    Freeman RD
    Neurol Clin; 1997 May; 15(2):411-20. PubMed ID: 9115471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood choline and response to clonazepam and haloperidol in Tourette's syndrome.
    Merikangas JR; Merikangas KR; Kopp U; Hanin I
    Acta Psychiatr Scand; 1985 Oct; 72(4):395-9. PubMed ID: 3865498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled family history study of Tourette's syndrome, I: Attention-deficit hyperactivity disorder and learning disorders.
    Comings DE; Comings BG
    J Clin Psychiatry; 1990 Jul; 51(7):275-80. PubMed ID: 2365665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome.
    Frankenburg FR; Kando JC
    J Clin Psychopharmacol; 1994 Oct; 14(5):359-60. PubMed ID: 7806695
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications for clonidine in child psychiatry].
    Dollfus S
    Encephale; 1993; 19(2):83-7. PubMed ID: 8275901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tourette's syndrome in Monroe County school children.
    Caine ED; McBride MC; Chiverton P; Bamford KA; Rediess S; Shiao J
    Neurology; 1988 Mar; 38(3):472-5. PubMed ID: 3162295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tics, Tourette's, and attention deficit hyperactivity disorders: connections and treatment.
    Mitchell A; Steffenson N; Hogan H; Gibson FH; Steffenson M
    MCN Am J Matern Child Nurs; 1996; 21(6):294-300. PubMed ID: 8952283
    [No Abstract]   [Full Text] [Related]  

  • 39. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder.
    McConville BJ; Fogelson MH; Norman AB; Klykylo WM; Manderscheid PZ; Parker KW; Sanberg PR
    Am J Psychiatry; 1991 Jun; 148(6):793-4. PubMed ID: 1817466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.